BioN­Tech dou­bles down on ADC part­ner MediLink in new $1.8B biobucks pact

As BioN­Tech’s pipeline tilts back to­ward on­col­o­gy, the Ger­man biotech is once again tap­ping a young Chi­nese part­ner in a bid for the next gen­er­a­tion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.